Tinguri 1,5 mg/ml Sirap Sverige - svenska - Läkemedelsverket (Medical Products Agency)

tinguri 1,5 mg/ml sirap

actavis group ptc ehf. - butamiratcitrat - sirap - 1,5 mg/ml - natriumbensoat hjälpämne; glycerol hjälpämne; sorbitol hjälpämne; butamiratcitrat 1,5 mg aktiv substans - butamirat

Dimethyl fumarate Mylan Europeiska unionen - svenska - EMA (European Medicines Agency)

dimethyl fumarate mylan

mylan ireland limited - dimetylfumarat - multipel skleros, skovvis förlöpande - immunsuppressiva - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Polpharma Europeiska unionen - svenska - EMA (European Medicines Agency)

dimethyl fumarate polpharma

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetylfumarat - multipel skleros, skovvis förlöpande - immunsuppressiva - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Neuraxpharm Europeiska unionen - svenska - EMA (European Medicines Agency)

dimethyl fumarate neuraxpharm

laboratorios lesvi s.l. - dimetylfumarat - multipel skleros, skovvis förlöpande - immunsuppressiva - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Teva Europeiska unionen - svenska - EMA (European Medicines Agency)

dimethyl fumarate teva

teva gmbh - dimetylfumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunsuppressiva - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Dimethyl fumarate Accord Europeiska unionen - svenska - EMA (European Medicines Agency)

dimethyl fumarate accord

accord healthcare s.l.u. - dimetylfumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunsuppressiva - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Dimethyl fumarate Newbury 240 mg Enterokapsel, hård Sverige - svenska - Läkemedelsverket (Medical Products Agency)

dimethyl fumarate newbury 240 mg enterokapsel, hård

newbury pharmaceuticals ab - dimetylfumarat - enterokapsel, hård - 240 mg - dimetylfumarat 240 mg aktiv substans; propylenglykol hjälpämne

Dimethyl fumarate Newbury 120 mg Enterokapsel, hård Sverige - svenska - Läkemedelsverket (Medical Products Agency)

dimethyl fumarate newbury 120 mg enterokapsel, hård

newbury pharmaceuticals ab - dimetylfumarat - enterokapsel, hård - 120 mg - dimetylfumarat 120 mg aktiv substans; propylenglykol hjälpämne

Vumerity Europeiska unionen - svenska - EMA (European Medicines Agency)

vumerity

biogen netherlands b.v. - diroximel fumarate (biib098) - multipel skleros, skovvis förlöpande - immunsuppressiva - vumerity is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (see section 5. 1 for important information on the populations for which efficacy has been established).

Dimethyl fumarate Sandoz 120 mg Enterokapsel, hård Sverige - svenska - Läkemedelsverket (Medical Products Agency)

dimethyl fumarate sandoz 120 mg enterokapsel, hård

sandoz a/s - dimetylfumarat - enterokapsel, hård - 120 mg - propylenglykol hjälpämne; dimetylfumarat 120 mg aktiv substans